Management of EGFR Inhibitor-induced Skin Toxicity and Factors Impacting Patients’ Adherence to Skin Toxicity Treatment: Health Care Provider and Patient Surveys in European Oncology Centers-Reference-Cited by-同舟云学术

Management of EGFR Inhibitor-induced Skin Toxicity and Factors Impacting Patients’ Adherence to Skin Toxicity Treatment: Health Care Provider and Patient Surveys in European Oncology Centers

Published:2020-06 Issue:2 Volume:19 Page:100-108.e9
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Kafatos George,Dube Sabada,Burdon Peter,Demonty Gaston,Flinois Alain,Leclerc Marjorie,Lowe Kimberly,Feudjo-Tepie Maurille,Segaert Siegfried

Funder

Amgen

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference26 articles.

1. A comprehensive pathway map of epidermal growth factor receptor signaling;Oda;Mol Syst Biol,2005

2. Therapeutic value of EGFR inhibition in CRC and NSCLC: 15 years of clinical evidence;Troiani;ESMO Open,2016

3. Biomarkers of skin toxicity induced by anti-epidermal growth factor receptor antibody treatment in colorectal cancer;Kubo;World J Gastroenterol,2016

4. Association between serum ligands and the skin toxicity of anti-epidermal growth factor receptor antibody in metastatic colorectal cancer;Takahashi;Cancer Sci,2015

5. Rash rates with egfr inhibitors: meta-analysis;Mittmann;Curr Oncol,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical observation of topical antipruritic spray acting on epidermal growth factor receptor tyrosine kinase inhibitor in the treatment of dermatitis;Medicine;2024-05-31

2. Risk factor analysis for anti-epidermal growth factor receptor monoclonal antibody–induced skin toxicities in real-world metastatic colorectal cancer treatment;Supportive Care in Cancer;2023-08

3. The health-related quality of life of lung cancer patients with EGFR-TKI-related skin adverse drug reactions and its relationship with coping style and self-management;Supportive Care in Cancer;2022-11-19

4. Experience of patients with lung cancer and with targeted therapy-related skin adverse drug reactions: A qualitative study;Asia-Pacific Journal of Oncology Nursing;2022-10

5. The relationship between medication literacy and skin adverse reactions in non-small-cell lung cancer patients undergoing targeted EGFR-TKI therapy;BMC Cancer;2022-05-03